Product Information

RUFINAMIDE 40 MG/ML SUSPENSION is a generic product labeled by Ascend Laboratories, LLC, priced at $0.2036 per ML under NDC 67877067362. Its NADAC has been published 277 times since May 5, 2021.

FDA first approved this application on Feb 23, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RUFINAMIDE 40 MG/ML SUSPENSION

Rufinamide
$0.2036per ML

Strength

40 mg/mL

NDC

67877067362

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

RUFINAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213410

FDA Approved

2/23/2021

TE Code

AB

On Market Since

2/24/2021

Price Statistics

The NADAC for RUFINAMIDE 40 MG/ML SUSPENSION has been published 277 times since May 5, 2021, and over the history we have for it it has declined 93.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2036 per ML
All-time high$3.2349 (Oct 13, 2021)
All-time low$0.2021 (Jul 22, 2026)
52-week high$0.3887
52-week low$0.2021
Median price$0.6034
Average price$1.0608
Largest weekly change-53.3% (Sep 20, 2023)
Weeks tracked277
Tracking sinceMay 5, 2021

Price History

1W

+0.7%

1M

+0.7%

3M

-14.9%

6M

-26.1%

1Y

-47.6%

3Y

-85.6%

5Y

-93.7%

All

-93.7%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of RUFINAMIDE 40 MG/ML SUSPENSION?

The current National Average Drug Acquisition Cost (NADAC) for RUFINAMIDE 40 MG/ML SUSPENSION, manufactured by Ascend Laboratories, LLC, is $0.2036 per ML (NDC 67877067362), effective Aug 19, 2026.

How has the price of RUFINAMIDE 40 MG/ML SUSPENSION changed over time?

Over the history we have for it, the NADAC for RUFINAMIDE 40 MG/ML SUSPENSION has declined 93.7%. It has been tracked across 277 weekly CMS publications since May 5, 2021.

What are the highest and lowest recorded NADAC prices for RUFINAMIDE 40 MG/ML SUSPENSION?

Since May 5, 2021, the NADAC for RUFINAMIDE 40 MG/ML SUSPENSION has ranged from a low of $0.2021 (Jul 22, 2026) to a high of $3.2349 (Oct 13, 2021), with a median of $0.6034 per ML.

Are there cheaper alternatives to RUFINAMIDE 40 MG/ML SUSPENSION?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RUFINAMIDE 40 MG/ML SUSPENSION in a comparable dosage form, but none are currently priced below it.

Who manufactures RUFINAMIDE 40 MG/ML SUSPENSION?

RUFINAMIDE 40 MG/ML SUSPENSION (NDC 67877067362) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.